Wynnefield Partners Small Cap Value, L.P. I 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-05 2:17 pm Purchase | 2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 5,007,666 16.000% | 80,871 (+1.64%) | Filing |
| 2024-07-02 4:54 pm Purchase | 2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 5,007,666 16.000% | 5,007,666 (New Position) | Filing |
| 2023-03-16 4:15 pm Purchase | 2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 4,926,795 16.600% | 464,285 (+10.40%) | Filing |
| 2022-12-02 4:15 pm Purchase | 2022-11-25 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 4,462,510 14.800% | 884,805 (+24.73%) | Filing |
| 2022-01-20 4:16 pm Purchase | 2022-01-12 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 3,577,705 12.100% | 387,400 (+12.14%) | Filing |
| 2021-04-20 4:15 pm Purchase | 2021-04-12 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 3,190,305 10.900% | 507,905 (+18.93%) | Filing |